186 related articles for article (PubMed ID: 20538694)
1. Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.
Hernandez-Guillamon M; Garcia-Bonilla L; Solé M; Sosti V; Parés M; Campos M; Ortega-Aznar A; Domínguez C; Rubiera M; Ribó M; Quintana M; Molina CA; Alvarez-Sabín J; Rosell A; Unzeta M; Montaner J
Stroke; 2010 Jul; 41(7):1528-35. PubMed ID: 20538694
[TBL] [Abstract][Full Text] [Related]
2. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke.
Hernandez-Guillamon M; Solé M; Delgado P; García-Bonilla L; Giralt D; Boada C; Penalba A; García S; Flores A; Ribó M; Alvarez-Sabin J; Ortega-Aznar A; Unzeta M; Montaner J
Cerebrovasc Dis; 2012; 33(1):55-63. PubMed ID: 22133888
[TBL] [Abstract][Full Text] [Related]
3. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
Sun P; Solé M; Unzeta M
Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
Sun P; Hernandez-Guillamón M; Campos-Martorell M; Simats A; Montaner J; Unzeta M; Solé M
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):542-553. PubMed ID: 29175057
[TBL] [Abstract][Full Text] [Related]
5. Origins of serum semicarbazide-sensitive amine oxidase.
Stolen CM; Yegutkin GG; Kurkijärvi R; Bono P; Alitalo K; Jalkanen S
Circ Res; 2004 Jul; 95(1):50-7. PubMed ID: 15178639
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
[TBL] [Abstract][Full Text] [Related]
7. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J
Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.
Montaner J; Molina CA; Monasterio J; Abilleira S; Arenillas JF; Ribó M; Quintana M; Alvarez-Sabín J
Circulation; 2003 Feb; 107(4):598-603. PubMed ID: 12566373
[TBL] [Abstract][Full Text] [Related]
9. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases.
Solé M; Unzeta M
Biol Cell; 2011 Nov; 103(11):543-57. PubMed ID: 21819380
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
[TBL] [Abstract][Full Text] [Related]
11. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
13. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.
Abella A; García-Vicente S; Viguerie N; Ros-Baró A; Camps M; Palacín M; Zorzano A; Marti L
Diabetologia; 2004 Mar; 47(3):429-438. PubMed ID: 14968297
[TBL] [Abstract][Full Text] [Related]
14. Vascular adhesion protein-1: Role in human pathology and application as a biomarker.
Pannecoeck R; Serruys D; Benmeridja L; Delanghe JR; van Geel N; Speeckaert R; Speeckaert MM
Crit Rev Clin Lab Sci; 2015; 52(6):284-300. PubMed ID: 26287391
[TBL] [Abstract][Full Text] [Related]
15. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
Castellanos M; Leira R; Serena J; Blanco M; Pedraza S; Castillo J; Dávalos A
Stroke; 2004 Jul; 35(7):1671-6. PubMed ID: 15166391
[TBL] [Abstract][Full Text] [Related]
16. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
Saposnik G; Demchuk A; Tu JV; Johnston SC;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis.
dela Peña IC; Yoo A; Tajiri N; Acosta SA; Ji X; Kaneko Y; Borlongan CV
J Cereb Blood Flow Metab; 2015 Feb; 35(2):338-46. PubMed ID: 25425079
[TBL] [Abstract][Full Text] [Related]
18. Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.
Murata M; Noda K; Kawasaki A; Yoshida S; Dong Y; Saito M; Dong Z; Ando R; Mori S; Saito W; Kanda A; Ishida S
Curr Eye Res; 2017 Dec; 42(12):1674-1683. PubMed ID: 28937866
[TBL] [Abstract][Full Text] [Related]
19. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
Krakovsky M; Polianski V; Nimrod A; Higazi A; Leker RR; Lamensdorf I
Neurol Res; 2011 Nov; 33(9):983-90. PubMed ID: 22081002
[TBL] [Abstract][Full Text] [Related]
20. A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke.
García-Yébenes I; Sobrado M; Zarruk JG; Castellanos M; Pérez de la Ossa N; Dávalos A; Serena J; Lizasoain I; Moro MA
Stroke; 2011 Jan; 42(1):196-203. PubMed ID: 21106952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
